alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**EX      32.2**

**CERTIFICATION      PURSUANT TO**

**18      U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906      OF THE SARBANES-OXLEY ACT OF 2002**

|   | (1)                          The Report fully complies with the requirements of section                13(a) or 15(d) of the Securities Exchange Act of 1934;                and |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (2)                          The information contained in the Report fairly presents, in                all                material respects, the financial condition and results of operations                of                Buckeye. |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Dated                this 6th                day of September, 2007 |   |
|---------------------------------------------------------------------|--------|
|                                                                |   |
|                                                                |   |
| /s/                Steven G. Dean                                   |   |
| Steven                G. Dean                                       |   |
| Senior                Vice President and Chief Financial Officer    |   |
Exhibit 31.2

                                  CERTIFICATION

     Pursuant to the requirements of Rules 13a-14 of the Securities Exchange Act
of 1934, as amended, James R. Musick provides the following certification.

     I, James R. Musick, Principal Financial Officer of Vitro Diagnostics, Inc.
("Company") certify that:

     1.   I have reviewed this quarterly report on Form 10-QSB of the Company;

     2.   Based on my knowledge, this quarterly report does not contain any
          untrue statement of a material fact or omit to state a material fact
          necessary to make the statements made, in light of the circumstances
          under which such statements were made, not misleading with respect to
          the period covered by this quarterly report;

     3.   Based on my knowledge, the financial statements, and other financial
          information included in the quarterly report, fairly present in all
          material respects the financial condition, results of operations and
          cash flows of the Company as of, and for, the periods presented in
          this quarterly report;

     4.   I am responsible for establishing and maintaining disclosure controls
          and procedures (as defined in Exchange Act Rules 13a-14 and 15-d-14)
          for the registrant and have designed such disclosure controls and
          procedures to ensure that material information relating to the Company
          is made know to me by others, particularly during the period in which
          this quarterly report is being prepared;

     5.   I have disclosed, based on my most recent evaluation, to the Company's
          auditors and the audit committee of our board of directors (or persons
          performing the equivalent functions):

          a.   All significant deficiencies in the design or operation of
               internal controls which could adversely affect the Company's
               ability to record, process, summarize and report financial date
               and have identified for the Company's auditors any material
               weaknesses in internal controls, and

          b.   Any fraud, whether or not material, that involves management or
               other employees which have a significant role in the Company's
               internal controls; and

     6.   I have indicated in this quarterly report whether or not there were
          significant changes in internal control or in other factors that could
          significantly affect internal controls subsequent to the date of my
          most recent evaluation, including any corrective actions with regard
          to significant deficiencies and material weaknesses.

Date: March 15, 2006
                                                /s/ James R. Musick
                                                -------------------
                                                James R. Musick, Chairman and
                                                Principle Financial Officer
[Federal Register Volume 74, Number 195 (Friday, October 9, 2009)]
[Notices]
[Page 52268]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-24530]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Sunshine Act; Federal Register Notice

Agency Holding the Meetings: Nuclear Regulatory Commission.

Date: Week of October 12, 2009.

Place: Commissioners' Conference Room, 11555 Rockville Pike, Rockville, 
Maryland.

Status: Public and Closed.

Additional Items To Be Considered: 

Week of October 12, 2009

Tuesday, October 13, 2009

9:15 a.m. Affirmation Session (Public Meeting) (Tentative). Calvert 
Cliffs 3 Nuclear Project LLC & UniStar Nuclear Operating Services LLC 
(Combined License App. Calvert Cliffs, Unit 3) Docket Nos. 52-016-COL, 
Calvert Cliffs 3 Nuclear Project LLC & UniStar Nuclear Operating 
Services, LLC, Appeal from LBP-09-4 (Tentative).
    *The schedule for Commission meetings is subject to change on short 
notice. To verify the status of meetings, call (recording)--(301) 415-
1292. Contact person for more information: Rochelle Bavol, (301) 415-
1651.
    The NRC Commission Meeting Schedule can be found on the Internet 
at: http://www.nrc.gov/about-nrc/policy-making/schedule.html.
    The NRC provides reasonable accommodation to individuals with 
disabilities where appropriate. If you need a reasonable accommodation 
to participate in these public meetings, or need this meeting notice or 
the transcript or other information from the public meetings in another 
format (e.g., braille, large print), please notify the NRC's Disability 
Program Coordinator, Rohn Brown, at 301-492-2279, TDD: 301-415-2100, or 
by e-mail at <a href="/cdn-cgi/l/email-protection#592b363137773b2b362e3719372b3a773e362f"><span class="__cf_email__" data-cfemail="e5978a8d8bcb87978a928ba58b9786cb828a93">[email protected]</span></a>. Determinations on requests for 
reasonable accommodation will be made on a case-by-case basis.
    This notice is distributed electronically to subscribers. If you no 
longer wish to receive it, or would like to be added to the 
distribution, please contact the Office of the Secretary, Washington, 
DC 20555 (301-415-1969), or send an e-mail to <a href="/cdn-cgi/l/email-protection#2c484d5e40494249025b5e454b44586c425e4f024b435a"><span class="__cf_email__" data-cfemail="2a4e4b58464f444f045d58434d425e6a445849044d455c">[email protected]</span></a>.

    Dated: October 5, 2009.
Rochelle C. Bavol,
Office of the Secretary.
[FR Doc. E9-24530 Filed 10-7-09; 4:15 pm]
BILLING CODE 7590-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 32
                    CERTIFICATION PURSUANT TO
                         18 U.S.C. 1350,
                     AS ADOPTED PURSUANT TO
          SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In  connection with the Quarterly Report of AEI Real Estate  Fund
XV Limited Partnership (the "Partnership") on Form 10-QSB for the
period  ended  June  30, 2003, as filed with the  Securities  and
Exchange  Commission  on  the  date hereof  (the  "Report"),  the
undersigned, Robert P. Johnson, President of AEI Fund  Management
86-A, Inc., the Managing General Partner of the Partnership,  and
Patrick  W. Keene, Chief Financial Officer of AEI Fund Management
86-A, Inc.,  each certify, pursuant to 18 U.S.C. 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

     1.   The  Report  fully  complies with the  requirements  of
          Section  13(a) or 15(d) of the Securities Exchange  Act
          of 1934; and

     2.   The   information  contained  in  the   Report   fairly
          presents,  in  all  material  respects,  the  financial
          condition and results of operations of the Partnership.


                              /s/ Robert P. Johnson
                              Robert P. Johnson, President
                              AEI Fund Management 86-A, Inc.
                              Managing General Partner
                              August 8, 2003



                              /s/ Patrick W. Keene
                              Patrick W. Keene, Chief Financial Officer
                              AEI Fund Management 86-A, Inc.
                              Managing General Partner
                              August 8, 2003
# C_2020040EN.01003301.xml

| 6.2.2020 | EN | Official Journal of the European Union | C 40/33 |
| --- | --- | --- | --- |

6.2.2020

EN

Official Journal of the European Union

C 40/33

---

EFTA COURT JUDGMENT OF THE COURT

of 13 November 2019

in Case E-2/19

D and E

(Free movement of persons – Sectoral adaptations for Liechtenstein – Right of residence – Derived right of residence for family members – Directive 2004/38/EC)

(2020/C 40/04)

In Case E-2/19, D and E – REQUEST to the Court under Article 34 of the Agreement between the EFTA States on the Establishment of a Surveillance Authority and a Court of Justice by the Administrative Court of the Principality of Liechtenstein (Verwaltungsgerichtshof des Fürstentums Liechtenstein) concerning the interpretation of Directive 2004/38/EC of the European Parliament and of the Council of 29 April 2004 on the right of citizens of the Union and their family members to move and reside freely within the territory of the Member States, as adapted to the Agreement on the European Economic Area, the Court, composed of Páll Hreinsson, President (Judge-Rapporteur), Bernd Hammermann and Ola Mestad (ad hoc), Judges, gave judgment on 13 November 2019, the operative part of which is as follows:

The sectoral adaptations to Annexes V and VIII to the EEA Agreement, in particular Point III thereof, do not deprive the family member of an EEA national, who has a valid residence permit and is residing in Liechtenstein, of the right to accompany or join the EEA national in Liechtenstein on the basis of Article 7(1)(d) of Directive 2004/38/EC, even though the residence permit that the EEA national in Liechtenstein holds was not granted on the basis of the system provided for in the sectoral adaptations.

---
I 

108TH CONGRESS 

1ST SESSION H. R. 2706

To clarify the treatment of tax attributes under section 108 of the Internal 

Revenue Code of 1986 for taxpayers which file consolidated returns. 

IN THE HOUSE OF REPRESENTATIVES 

JULY 10, 2003

Mr. MCCRERY (for himself, Mr. MCINNIS, and Mr. MATSUI) introduced the 

following bill; which was referred to the Committee on Ways and Means 

A BILL

To clarify the treatment of tax attributes under section 108 

of the Internal Revenue Code of 1986 for taxpayers 

which file consolidated returns.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. CLARIFICATION OF THE TREATMENT OF TAX 

4 ATTRIBUTES.

5 (a) IN GENERAL.—Section 108(b) of the Internal 

6 Revenue Code of 1986 (relating to reduction of tax at7 tributes) is amended by adding at the end the following 

8 new paragraph: 

9 ‘‘(6) AFFILIATED GROUPS.—If the tax10 payer is a member of an affiliated group of cor-
2

•HR 2706 IH 

1 porations which files a consolidated return 

2 under section 1501, the tax attributes described 

3 in paragraph (1) shall be the aggregate tax at4 tributes of such group. The Secretary shall pre5 scribe such regulations as may be necessary 

6 under section 1502 to carry out the purposes of 

7 this paragraph.’’. 

8 (b) EFFECTIVE DATE.—The amendment made by 

9 subsection (a) shall apply to discharges of indebtedness 

10 occurring after June 25, 2003, except that discharges of 

11 indebtedness under any plan of reorganization in a case 

12 under title 11, United States Code, shall be deemed to 

13 occur on the date such plan is confirmed.

Æ
# C_2009247EN.01001001.xml

| 15.10.2009 | EN | Official Journal of the European Union | C 247/10 |
| --- | --- | --- | --- |

15.10.2009

EN

Official Journal of the European Union

C 247/10

---

Authorisation of State aid pursuant to Article 61 of the EEA Agreement and Article 1(3) in Part 1 of Protocol 3 to the Surveillance and Court Agreement

2009/C 247/06

The EFTA Surveillance Authority raises no objections to the following aid measure:

| Date of adoption | : | 10 June 2009 |
| --- | --- | --- |
| Case number | : | 66338 |
| EFTA State | : | Iceland |
| Title | : | Amendment of the scheme — Temporary reimbursement in respect of film making in Iceland |
| Legal basis | : | Act No 39/2009 of 2 April 2009 amending Act No 43/1999 on Temporary Reimbursements in Respect of Film Making In Iceland |
| Objective | : | Promotion of cultural work for cinema or television |
| Form of aid | : | Direct aid |
| Duration | : | 31 December 2011 |
| Name and address of the granting authority | : | Icelandic Ministry of Industry Arnarhváli |
| 150 Reykjavik |
| ICELAND |

Date of adoption

:

10 June 2009

Case number

:

66338

EFTA State

:

Iceland

Title

:

Amendment of the scheme — Temporary reimbursement in respect of film making in Iceland

Legal basis

:

Act No 39/2009 of 2 April 2009 amending Act No 43/1999 on Temporary Reimbursements in Respect of Film Making In Iceland

Objective

:

Promotion of cultural work for cinema or television

Form of aid

:

Direct aid

Duration

:

31 December 2011

Name and address of the granting authority

:

Icelandic Ministry of Industry Arnarhváli

150 Reykjavik

ICELAND

The authentic text of the decision, from which all confidential information has been removed, can be found at:

http://www.eftasurv.int/fieldsofwork/fieldstateaid/stateaidregistry/

---
Exhibit
32.2




CERTIFICATION
PURSUANT TO


SECTION
1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002




In
connection with the Quarterly Report of Theragenics Corporation, (the “Company”)
on Form 10-Q for the period ended April 5, 2009 as filed with the Securities and
Exchange Commission on the date hereof (the “Report”), I, Francis J. Tarallo,
Chief Financial Officer, certify pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


(1)
            The
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the Securities Exchange Act of 1934; and(2)
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the Company
      as of the dates and for the periods referred to in the
    Report.




Date: May
      12, 2009
                By:
                /s/
      Francis J. TaralloFrancis
      J. TaralloChief
      Financial Officer




A signed
original of this written statement required by Section 906 has been provided to
Theragenics Corporation and will be retained by Theragenics Corporation and
furnished to the Securities and Exchange Commission or its staff upon
request.
United States Court of Appeals

For the Eighth Circuit

___________________________

No. 23-2225

___________________________

Liam Lefebvre

lllllllllllllllllllllPlaintiff - Appellant

v.

Washington University in St. Louis

lllllllllllllllllllllDefendant - Appellee

 ____________

Appeal from United States District Court 

for the Eastern District of Missouri - St. Louis

 ____________

 Submitted: April 30, 2024

Filed: May 6, 2024

[Unpublished]

____________

Before LOKEN, SMITH, and KELLY, Circuit Judges. 

____________

PER CURIAM.

Liam Lefebvre appeals the district court’s1 dismissal of his breach-of-contract

claims in this diversity action against Washington University in St. Louis. Upon

1The Honorable Stephen R. Clark, Chief Judge, United States District Court for

the Eastern District of Missouri.
careful review, we conclude that Lefebvre failed to adequately allege a breach-ofcontract claim under Missouri law. See Du Bois v. Bd. of Regents of the Univ. of

Minn., 987 F.3d 1199, 1202 (8th Cir. 2021) (standard of review). 

Accordingly, we affirm the judgment of the district court. We also deny

Lefebvre’s motion to file his reply brief out of time. 

______________________________

-2-
I 

108TH CONGRESS 

1ST SESSION H. R. 2934

To increase criminal penalties relating to terrorist murders, deny Federal 

benefits to terrorists, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JULY 25, 2003

Mr. CARTER introduced the following bill; which was referred to the 

Committee on the Judiciary 

A BILL

To increase criminal penalties relating to terrorist murders, 

deny Federal benefits to terrorists, and for other purposes.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Terrorist Penalties En5 hancement Act of 2003’’. 

6 SEC. 2. PENALTIES FOR TERRORIST MURDERS. 

7 (a) Chapter 113B of title 18, United States Code, 

8 is amended—
2

HR 2934 IH 

1 (1) in the chapter analysis, by inserting at the 

2 end the following:

‘‘2339D. Terrorist offenses resulting in death.’’;

3 and 

4 (2) by inserting at the end the following: 

5 ‘‘§ 2339D. Terrorist offenses resulting in death 

6 ‘‘(a) A person who, in the course of committing a ter7 rorist offense, engages in conduct that results in the death 

8 of a person, shall be punished by death or imprisoned for 

9 any term of years or for life. 

10 ‘‘(b) As used in this section, ‘terrorist offense’ 

11 means—

12 ‘‘(1) international or domestic terrorism as de13 fined in section 2331; 

14 ‘‘(2) a Federal crime of terrorism as defined in 

15 section 2332b(g); 

16 ‘‘(3) an offense under this chapter, section 175, 

17 175b, 229, or 831, or section 236 of the Atomic En18 ergy Act of 1954 (42 U.S.C. 2284); or 

19 ‘‘(4) an attempt or conspiracy to commit an of20 fense described in paragraph (10), (2), or (3).’’. 

21 (b) Section 3592(c)(1) of title 18, United States 

22 Code, is amended by inserting ‘‘section 2339D (terrorist 

23 offenses resulting in death),’’ after ‘‘destruction),’’. 
3

HR 2934 IH 

1 SEC. 3. DENIAL OF FEDERAL BENEFITS TO TERRORISTS. 

2 Chapter 113B of title 18, United States Code, is 

3 amended—

4 (1) in the chapter analysis, by adding at the 

5 end the following:

‘‘2339E. Denial of federal benefits to terrorists.’’;

6 and 

7 (2) by adding at the end the following: 

8 ‘‘§ 2339E. Denial of federal benefits to terrorists 

9 ‘‘(a) IN GENERAL.—Any individual who is convicted 

10 of a Federal crime of terrorism (as defined in section 

11 2332b(g)(5)) shall, as provided by the court on motion of 

12 the government, be ineligible for any or all Federal bene13 fits for any term of years or for life. 

14 ‘‘(b) DEFINITION.—As used in this section, ‘Federal 

15 benefit’ has the meaning given that term in section 421(d) 

16 of the Controlled Substances Act (21 U.S.C. 862(d)).’’.

Æ
**Exhibit 23.1**

 

**CONSENT OF INDEPENDENT AUDITORS**

 

The Board of Directors 

Calypte Biomedical Corporation 

 

We consent to the incorporation by reference in the registration statements No. 333-16769, No. 333-70890, No. 333-97083 and No. 333-101578 on Form S-8, the registration statements No. 333-38417, No. 333-66765, No. 333-75239, and No.333-32246 on Form S-3, and in the registration statement No. 333-72268 on Form S-2 of Calypte Biomedical Corporation of our reports dated February 8, 2002 relating to the consolidated balance sheets of Calypte Biomedical Corporation and subsidiaryas of December 31, 2001 and 2000, and the related consolidated statements of operations, stockholders equity (deficit) and cash flows for each of the years in the three-year period ended December 31, 2001 and the related consolidated financialstatement schedule, which reports appear in the December 31, 2001 annual report on Form 10-K/A (Amendment No. 3) of Calypte Biomedical Corporation. 

 

The accompanying consolidated financial statements and the related consolidated financial statement schedule have been prepared assumingthat the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company has suffered recurring losses from operations and has an accumulated deficit that raise substantial doubt about itsability to continue as a going concern. Managements plans in regard to these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

/s/    KPMG LLP 

 

SanFrancisco, California 

February 4, 2003
HomeOffice of the SpokespersonPress Releases...Return to Pre-Pandemic Passport Processing Times

# 									Return to Pre-Pandemic Passport Processing Times							

Media Note

Office of the Spokesperson

December 18, 2023

Passport processing times have returned to our pre-pandemic norm. As of December 18, 2023, passport applications will be processed within 6-8 weeks for routine service and 2-3 weeks for expedited service, which costs an additional $60. With this update, we have fulfilled our commitment to return to benchmarks from March 2020. This reflects the work of dedicated employees working for the American people.

In 1990, only five percent of Americans had a passport. Today, that number is 48%. More Americans can travel abroad now than at any time in our history. There are now over 160 million valid U.S. passports in circulation (nearly double the amount from 2007).

This past year, the Department experienced unprecedented demand for passports. Between October 2022 and September 2023 (the federal fiscal year), the Department of State issued over 24 million passport books and cards – the highest amount ever in our nation’s history.

We have worked hard to modernize and improve the service we provide to the American people. We will continue to do so in 2024.

Visit travel.state.gov/passport to plan your 2024 travel with the latest passport guidance and processing tips in mind. We encourage all U.S. citizens traveling overseas to renew their passports early. We also advise the U.S. traveling public to enroll in the Department of State’s Smart Traveler Enrollment Program (STEP.state.gov) so they can receive important messages about their destinations directly, including timely Alerts and updates to Travel Advisories.

Tags

Bureau of Consular AffairsOffice of the SpokespersonPassports

Back to Top